You just read:

Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)

News provided by

Athira Pharma, Inc.

Jul 16, 2019, 12:30 ET